Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
about
Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brainHistory of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.Migraine and stroke: current perspectives.Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: a review.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs.Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.The Levels of Circulating Proangiogenic Factors in Migraineurs.Cranial and peripheral interictal vascular changes in migraine patients.
P2860
Q35045324-B3D36E06-64C8-4963-A22C-1849EDF8A4AFQ37155841-051ECE73-8CD2-4169-B8A4-2284F37D2634Q37282908-3FE6FCE2-B555-437C-AAC3-94BC09C03121Q37996578-36C826E8-1E6A-4BFB-8FAA-52F964D487EBQ38099236-2E38B3C5-B1BF-44CD-9792-4BA37F99DE39Q38167355-291A498A-0A08-4188-9C89-3F4BA439F4DDQ38215048-169DDB83-6B39-49DE-8242-AC39B0E2FE15Q43885764-90F6A5B8-A355-43DB-B79F-13CE4D9D04B4Q47156884-B38735B2-3E51-4242-9C7B-88CD17A4FBF3Q48380620-0EE45DA7-B53C-4AE2-B2C6-BD03423C533C
P2860
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@ast
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@en
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@nl
type
label
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@ast
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@en
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@nl
prefLabel
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@ast
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@en
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@nl
P2093
P2860
P1476
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
@en
P2093
H A Struijker-Boudier
H H Thijssen
J N de Hoon
L M Van Bortel
P2860
P356
10.1046/J.0306-5251.2001.01415.X
P407
P577
2001-07-01T00:00:00Z